ArticleFrontiers in gastroenterology (Lausanne, Switzerland)2023

Case Report: Primary small bowel adenocarcinoma with peritoneal metastasis responded well to a CapeOX + bevacizumab regimen.

Guang Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.